EASD 2018 - Symposia ProgrammeEASD 2018 - MTE SessionsEASD 2018 - SponsorsBecome a sponsor at EASD 2019
Helen Colhoun
Thursday
18:30-20:00
Ehrlich Hall
High CV risk populations who may benefit the most from PCSK9i therapy: highlights from the most recent ODYSSEY OUTCOMES data
Ulrich Laufs
Legal NoticeData Protection